Chemical carcinogens contribute to TCC by causing mutations in the DNA of urothelial cells. For instance, aromatic amines, found in certain industrial settings, can be metabolically activated to form highly reactive intermediates that bind to DNA, resulting in genotoxicity. This can lead to uncontrolled cellular proliferation and eventually tumor formation. Toxicologists investigate these processes to identify potential biomarkers for early detection and strategies for prevention.
